Swiss National Bank
BRLI

Swiss National Bank’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Swiss National Bank’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-29,600
Closed -$1.22M – 2576
2015
Q2 		$1.22M Buy
29,600
+800
+3% +$28.7K ﹤0.01% 1671
2015
Q1 		$1.01M Hold
28,800
– – ﹤0.01% 1759
2014
Q4 		$925K Buy
28,800
+600
+2% +$17.4K ﹤0.01% 1777
2014
Q3 		$791K Sell
28,200
-600
-2% -$18.3K ﹤0.01% 1810
2014
Q2 		$870K Hold
28,800
– – ﹤0.01% 1805
2014
Q1 		$797K Buy
28,800
+6,300
+28% +$165K ﹤0.01% 1843
2013
Q4 		$575K Hold
22,500
– – ﹤0.01% 1898
2013
Q3 		$672K Sell
22,500
-1,200
-5% -$33.4K ﹤0.01% 1737
2013
Q2 		$681K Buy
+23,700
New +$653K ﹤0.01% 1697

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Swiss National Bank's BRLI Position: Q3 2015 in Review

Swiss National Bank sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 29,600 shares — an estimated $1.22M sold.

Swiss National Bank first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $1.22M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Swiss National Bank reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Swiss National Bank sold 29,600 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $1.22M.
  • Swiss National Bank first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Swiss National Bank's BIO-REFERENCE LABS INC-NEW- position peaked at $1.22M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Swiss National Bank's 13F filing for Q3 2015, filed 4 Nov 2015.